EUVIMEDEUVIMED entdecken
Crossref

Noninvasive in vivo tracking of SPIONs-labeled CLDN18.2-targeted CAR-T cells in gastric cancer via magnetic particle imaging

Meng He, Lijie Ge, Hui Hui, Yali Zhou, Yingxiu Tang, Lin Shen, Jie Tian, Bo Wu, Changsong Qi, Yang Du, Lei Tang

Translational Research · 2025

DOI: 10.1016/j.trsl.2025.08.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Research, 2025. Verfasst von Meng He und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and I…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Claudins, Receptors, Chimeric Antigen, T-Lymphocytes. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Peking University, Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to employ magnetic particle imaging (MPI) for in vivo tracking and quantitative assessment of targeting capability of CLDN18.2-specific CAR-T cells. CLDN18.2-targeted CAR-T cells were labeled with superparamagnetic iron oxide nanoparticles (SPIONs) for magnetic particle imaging (MPI), and with the near-infrared fluorescent dye DiR for fluorescence molecular imaging (FMI) before infusion. SPIONs-labeled and unlabeled CAR-T cells were administered intravenously to NOD/SCID mice bearing HGC27 xenograft tumors, either independently or in combination with anti-PD-L1 (aPD-L1) antibody (n = 3 for imaging and n = 5 for treatment). The FMI and MPI successfully monitored the dynamic migration and tumor targeting of CAR-T cells towards CLDN18.2-overexpressing tumors. On the fifth day post-infusion, the MPI signal of SPIONs-labeled CAR-T cells was significantly higher in the tumor than that of labeled normal T cells. MPI combined with FMI successfully monitored the targeting of CLDN18.2-specific CAR-T cells in gastric cancer, providing a potential framework for evaluating CAR-T therapy combined with aPD-L1 immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsClaudinsReceptors, Chimeric AntigenT-LymphocytesCell TrackingMagnetic Iron Oxide NanoparticlesMagnetite NanoparticlesAnimalsHumansMice, Inbred NODMiceMice, SCIDCell Line, TumorImmunotherapy, AdoptiveFemaleXenograft Model Antitumor AssaysMolecular Imaging

Stichwörter der Autor:innen

Chimeric Antigen Receptor T (CAR)-T, Superparamagnetic iron oxide nanoparticles…Fluorescence molecular imaging (FMI)Gastric cancer (GC)Magnetic particle imaging (MPI)

Substanzen

ClaudinsCLDN18 protein, humanReceptors, Chimeric AntigenMagnetite Nanoparticles

Autor:innen und Institutionen

  • Department of Radiology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, China; CAS Key Laboratory of Molecular Imagi…
  • Department of Histology and Embryology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
  • CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China; National Key Laboratory of Kidney Diseases, Beijing 1008…
  • Bioheng Therapeutics, Nanjing, China.
  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Oncology, Peking University Cancer…
  • CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China; Key Laboratory of Big Data-Based Precision Medicine (Bei…

Förderung

  • Peking University
  • Natural Science Foundation of Beijing Municipality
  • National Natural Science Foundation of China

Zitieren

APA

He, M., Ge, L., Hui, H., Zhou, Y., Tang, Y., Shen, L., Tian, J., Wu, B., Qi, C., Du, Y., & Tang, L. (2025). Noninvasive in vivo tracking of SPIONs-labeled CLDN18.2-targeted CAR-T cells in gastric cancer via magnetic particle imaging. Translational Research. https://doi.org/10.1016/j.trsl.2025.08.002

Vancouver

He M, Ge L, Hui H, Zhou Y, Tang Y, Shen L, et al. Noninvasive in vivo tracking of SPIONs-labeled CLDN18.2-targeted CAR-T cells in gastric cancer via magnetic particle imaging. Translational Research. 2025. doi:10.1016/j.trsl.2025.08.002

BibTeX
@article{He2025,
  author = {He, Meng and Ge, Lijie and Hui, Hui and Zhou, Yali and Tang, Yingxiu and Shen, Lin and Tian, Jie and Wu, Bo and Qi, Changsong and Du, Yang and Tang, Lei},
  title = {Noninvasive in vivo tracking of SPIONs-labeled CLDN18.2-targeted CAR-T cells in gastric cancer via magnetic particle imaging},
  journal = {Translational Research},
  year = {2025},
  doi = {10.1016/j.trsl.2025.08.002}
}
Kostenlos starten →